Atea Pharmaceuticals, Inc. (AVIR)
5.35
-0.10
(-1.83%)
USD |
NASDAQ |
Aug 28, 13:49
Atea Pharmaceuticals Price to Book Value : 2.102 for Aug. 28, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 27, 2026 | 2.141 |
| August 26, 2026 | 2.165 |
| August 25, 2026 | 2.133 |
| August 24, 2026 | 2.165 |
| August 21, 2026 | 2.133 |
| August 20, 2026 | 2.106 |
| August 19, 2026 | 2.196 |
| August 18, 2026 | 2.074 |
| August 17, 2026 | 2.051 |
| August 14, 2026 | 2.011 |
| August 13, 2026 | 1.992 |
| August 12, 2026 | 1.988 |
| August 11, 2026 | 1.984 |
| August 10, 2026 | 1.972 |
| August 07, 2026 | 2.062 |
| August 06, 2026 | 1.960 |
| August 05, 2026 | 1.866 |
| August 04, 2026 | 1.846 |
| August 03, 2026 | 1.811 |
| July 31, 2026 | 1.846 |
| July 30, 2026 | 1.862 |
| July 29, 2026 | 1.815 |
| July 28, 2026 | 1.772 |
| July 27, 2026 | 1.894 |
| July 24, 2026 | 1.858 |
| Date | Value |
|---|---|
| July 23, 2026 | 1.866 |
| July 22, 2026 | 1.890 |
| July 21, 2026 | 1.913 |
| July 20, 2026 | 1.876 |
| July 17, 2026 | 1.913 |
| July 16, 2026 | 1.852 |
| July 15, 2026 | 1.909 |
| July 14, 2026 | 1.846 |
| July 13, 2026 | 1.862 |
| July 10, 2026 | 1.960 |
| July 09, 2026 | 1.929 |
| July 08, 2026 | 1.890 |
| July 07, 2026 | 1.917 |
| July 06, 2026 | 1.913 |
| July 02, 2026 | 1.956 |
| July 01, 2026 | 1.878 |
| June 30, 2026 | 1.827 |
| June 29, 2026 | 1.579 |
| June 26, 2026 | 1.538 |
| June 25, 2026 | 1.490 |
| June 24, 2026 | 1.534 |
| June 23, 2026 | 1.534 |
| June 22, 2026 | 1.503 |
| June 18, 2026 | 1.493 |
| June 17, 2026 | 1.483 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Filana Therapeutics, Inc. | 0.6980 |
| CorMedix, Inc. | 1.404 |
| Eloxx Pharmaceuticals, Inc. | 1.350 |
| Cannabis Global, Inc. | -- |
| Breakthrough Chemistry, Inc. | 4.474 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0861 |
| Price | 5.35 |
| Earnings Yield | -39.09% |
| Market Cap | 429.10M |
| PEGY Ratio | -0.0861 |